Quinpirole elicits differential in vivo changes in the pre- and postsynaptic distributions of dopamine D2 receptors in mouse striatum: Relation to cannabinoid-1 (CB1) receptor targeting

Psychopharmacology

Volumn 221, Issue 1, 2012, Pages 101-113

  Lane, Diane A ^a   Chan, June ^a   Fitzgerald, Megan L ^a   Kearn, Chris S ^b   Mackie, Ken ^c   Pickel, Virginia M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Caudate putamen nucleus; Drug addiction; Marijuana; Motor inhibition; Nucleus accumbens shell; Reward

Indexed keywords

CANNABINOID 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; PENTOBARBITAL; QUINPIROLE;

ANIMAL EXPERIMENT; ANTIBODY LABELING; ARTICLE; CAUDATE NUCLEUS; CELL MEMBRANE; CONTROLLED STUDY; CORPUS STRIATUM; CYTOPLASM; DRUG TARGETING; IMMUNOGOLD LABELING; IN VIVO STUDY; INTERNALIZATION; LOCOMOTION; MALE; MOTIVATION; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC MEMBRANE; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANIMALS; CORPUS STRIATUM; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEURONS; NUCLEUS ACCUMBENS; POST-SYNAPTIC DENSITY; PRESYNAPTIC TERMINALS; PROTEIN TRANSPORT; QUINPIROLE; RECEPTOR, CANNABINOID, CB1; RECEPTORS, DOPAMINE D2;

EID: 84859630683     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2553-4     Document Type: Article

References (77)

1. Artigas F (2010) The prefrontal cortex: a target for antipsychotic drugs. Acta Psychiatr Scand 121:11-21
2. Balleine B, Delgado M, Hikosaka O (2007) The role of the dorsal striatum in reward and decision-making. Journal of Neuroscience 27:8161-8165 (Pubitemid 47219597)
3. Bamford NS, Zhang H, Schmitz Y, Wu NP, Cepeda C, Levine MS, Schmauss C, Zakharenko SS, Zablow L, Sulzer D (2004) Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 42:653-663 (Pubitemid 38639883)
4. Belin D, Jonkman S, Dickinson A, Robbins TW, Everitt BJ (2009) Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction. Behav Brain Res 199:89-102
5. Bellocchio E, Hu H, Pohorille A, Chan J, Pickel V, Edwards R (1998) The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission. J Neurosci 18:8648-8659 (Pubitemid 28491731)
6. Besson M, Belin D, McNamara R, Theobald D, Castel A, Beckett V, Crittenden B, Newman A, Everitt B, Robbins T, Dalley J (2010) Dissociable control of impulsivity in rats by dopamine d2/3 receptors in the core and shell subregions of the nucleus accumbens. Neuropsychopharmacology 35:560-569
7. Bortolato M, Aru G, Fa M, Frau R, Orru M, Salis P, Casti A, Luckey G, Mereu G, Gessa G (2005) Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle. Neuropsychopharmacology 30:561-574 (Pubitemid 40271158)
8. Bouaboula M, Bianchini L, McKenzie F, Pouyssegur J, Casellas P (1999) Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE-1 isoform via Gi-mediated mitogen activated protein kinase signaling transduction pathways. FEBS Lett 449:61-65 (Pubitemid 29182672)
9. Brana C, Aubert I, Charron G, Pellevoisin C, Bloch B (1997) Ontogeny of the striatal neurons expressing the D2 dopamine receptor in humans: an in situ hybridization and receptor-binding study. Mol Brain Res 48:389-400 (Pubitemid 27394926)
10. Chan J, Aoki C, Pickel V (1990) Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Methods 33:113-127 (Pubitemid 20276294)
11. Charara A, Smith Y, Parent A (1996) Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J Comp Neurol 364:254-266
12. Churchill L, Austin MC, Kalivas PW (1992) Dopamine and endogenous opioid regulation of picrotoxin-induced locomotion in the ventral pallidum after dopamine depletion in the nucleus accumbens. Psychopharmacology (Berl) 108:141-146
13. Del Arco A, Mora F (2009) Neurotransmitters and prefrontal cortexlimbic system interactions: implications for plasticity and psychiatric disorders. J Neural Transm 116:941-952
14. Delle Donne KT, Sesack SR, Pickel VM (1997) Ultrastructural immunocytochemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum. Brain Res 746:239-255 (Pubitemid 27060352)
15. Durstewitz D, Seamans J, Sejnowski T (2000) Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. J Neurophysiol 83:1733-1750 (Pubitemid 30159594)
16. Eilam D, Szechtman H (1989) Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur J Pharmacol 161:151-157 (Pubitemid 19080497)
17. Franklin K, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic, San Diego
18. Garcia-Sanz A, Badia A, Clos M (2001) Differential effect of quinpirole and 7-OH-DPAT on the spontaneous [(3)H]-dopamine efflux from rat striatal synaptosomes. Synapse 40:65-73 (Pubitemid 32179849)
19. Giuffrida A, Parsons L, Kerr T, Rodriguez dF, Navarro M, Piomelli D (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2:358-363 (Pubitemid 30491279)
20. Glass M, Felder C (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J of Neurosci 17:5327-5333
21. Gorriti MA, Ferrer B, del Arco I, Bermudez-Silva FJ, de Diego Y, Fernandez-Espejo E, Navarro M, Rodriguez de Fonseca F (2005) Acute delta9-tetrahydrocannabinol exposure facilitates quinpiroleinduced hyperlocomotion. Pharmacol Biochem Behav 81:71-77 (Pubitemid 40718954)
22. Gruenberg J, Griffiths G, Howell K (1989) Characterization of the early endosome and putative endocytic carrier vesicles in vivo and with an assay of vesicle fusion in vitro. J Cell Biol 108:1301-1316 (Pubitemid 19097039)
23. Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI (1997) Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol 388:211-227 (Pubitemid 27471497)
24. Hooks M, Kalivas P (1995) The role of mesoaccumbens-pallidal circuitry in novelty-induced behavioral activation. Neurosci 64:587-597
25. Ikemoto S (2002) Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1/D2 agonists. Neuroscience 113:939-955
26. Jarrahian A, Watts VJ, Barker EL (2004) D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor. J Pharmacol Exp Ther 308:880-886 (Pubitemid 38263961)
27. Kalivas PW, Duffy P (1997) Dopamine regulation of extracellular glutamate in the nucleus accumbens. Brain Res 761:173-177 (Pubitemid 27314749)
28. Kalivas P, Churchill L, Klitenick M (1993) GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neurosci 57:1047-1060 (Pubitemid 23355006)
29. Katona I, Rancz E, Acsady L, Ledent C, Mackie K, Hajos N, Freund T (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21:9506-9518 (Pubitemid 33096895)
30. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi E, Mackie K, Freund T (1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19:4544-4558 (Pubitemid 29241104)
31. Kearn C, Blake-Palmer K, Daniel E, Mackie K, Glass M (2005) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol Pharmacol 67:1697-1704 (Pubitemid 40594170)
32. Kienast T, Heinz A (2006) Dopamine and the diseased brain. CNS Neurol Disord Drug Targets 5:109-131 (Pubitemid 43796630)
33. Kim O, Ariano M, Namkung Y, Marinec P, Kim E, Han J, Sibley D (2008) D2 dopamine receptor expression and trafficking is regulated through direct interactions with ZIP. J Neurochem 106:83-95 (Pubitemid 351840200)
34. Kita J, Parker L, Phillips P, Garris P, Wightman R (2007) Paradoxical modulation of short-term facilitation of dopamine release by dopamine autoreceptors. J Neurochem 102:1115-1124 (Pubitemid 47174232)
35. Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M, Mukherjee J, Bilder RM, Brody AL, Mandelkern MA (2009) Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci 29:14734-14740
36. Leranth C, Pickel V, Heimer L, Zaborszky L (1989) Electron microscopic pre-embedding double immunostaining methods Neuroanatomical Tract-tracing Methods 2: Recent Progress. Plenum Publishing Co., New York, pp 129-172
37. Martin AB, Fernandez-Espejo E, Ferrer B, Gorriti MA, Bilbao A, NavarroM, Rodriguez de Fonseca F, Moratalla R (2008) Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacol 33:1667-1679 (Pubitemid 351684717)
38. McDonald AJ, Muller JF, Mascagni F (2002) GABAergic innervation of alpha type II calcium/calmodulin-dependent protein kinase immunoreactive pyramidal neurons in the rat basolateral amygdala. J Comp Neurol 446:199-218 (Pubitemid 34246040)
39. Meschler J, Conley T, Howlett A (2000) Cannabinoid and dopamine interaction in rodent brain: effects on locomotor activity. Pharmacol Biochem Behav 67:567-573 (Pubitemid 32103567)
40. Missale C, Nash S, Robinson S, Jaber M, Caron M (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189-225 (Pubitemid 28070979)
41. Mogenson G, Wu M (1991) Effects of administration of dopamine D2 agonist quinpirole on exploratory locomotion. Brain Res 551:216-220
42. Mulder J, Aguado T, Keimpema E, Barabas K, Ballester Rosado CJ, Nguyen L, Monory K, Marsicano G, Di Marzo V, Hurd YL, Guillemot F, Mackie K, Lutz B, Guzman M, Lu HC, Galve- Roperh I, Harkany T (2008) Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc Natl Acad Sci USA 105:8760-8765 (Pubitemid 351987753)
43. Murer M, Dziewczapolski G, Salin P, Vila M, Tseng K, Ruberg M, Rubinstein M, Kelly M, Grandy D, Low M, Hirsch E, Raisman-Vozari R, Gershanik O (2000) The indirect basal ganglia pathway in dopamine D(2) receptor-deficient mice. Neuroscience 99:643-650
44. Namkung Y, Dipace C, Javitch JA, Sibley DR (2009) G proteincoupled receptor kinase-mediated phosphorylation regulates postendocytic trafficking of the D2 dopamine receptor. J Biol Chem 284:15038-15051
45. Nicola S (2007) The nucleus accumbens as part of a basal ganglia action selection circuit. Psychopharmacology (Berl) 191:521-550
46. NirenbergM, Chan J, Pohorille A, Vaughan R, Uhl G, KuharM, Pickel V (1997) The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J Neurosci 17:6899-6907 (Pubitemid 27427868)
47. Noble E (2003) D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet 116B:103-125
48. O'Neill C, Evers-Donnelly A, Nicholson D, O'Boyle KM, O'Connor JJ (2009) D2 receptor-mediated inhibition of dopamine release in the rat striatum in vitro is modulated by CB1 receptors: studies using fast cyclic voltammetry. J Neurochem 108:545-551
49. Oertel W, Mugnaini E (1984) Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems. Neurosci Lett 47:233-238 (Pubitemid 14081892)
50. Ong W, Mackie K (1999) A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord. J Neurocytol 28:39-45 (Pubitemid 30040768)
51. Patel S, Rademacher D, Hillard C (2003) Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. J Pharmacol Exp Ther 306:880-888 (Pubitemid 37025293)
52. Peters A, Palay S, Webster H (1991) The fine structure of the nervous system. Oxford University Press, New York
53. Pickel V, Chan J, Kash T, Rodriguez J, Mackie K (2004) Compartment-specific localization of cannabinoid 1 (CB1) and [mu]-opioid receptors in rat nucleus accumbens. Neuroscience 127:101-112 (Pubitemid 38829156)
54. Pickel V, Chan J, Kearn C, Mackie K (2006) Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J Comp Neurol 495:299-313 (Pubitemid 43271474)
55. Pickel V, Heras A (1996) Ultrastructural localization of calbindin-D 28 k and GABA in the matrix compartment of the rat caudate-putamen nuclei. Neuroscience 71:167-178
56. Pickel V, Nirenberg M, Milner T (1997) Ultrastructural view of central catecholaminergic transmission: immunocytochemical localization of synthesizing enzymes, transporters and receptors. J Neurocytol 25:843-856 (Pubitemid 27032368)
57. Prekeris R, Klumperman J, Chen Y, Scheller R (1998) Syntaxin 13 mediates cycling of plasma membrane proteins via tubulovesicular recycling endosomes. J Cell Biol 143:957-971 (Pubitemid 28547396)
58. Przybyla JA, Watts VJ (2010) Ligand-induced regulation and localization of cannabinoid CB1 and dopamine D2L receptor heterodimers. J Pharmacol Exp Ther 332:710-719
59. Reynolds E (1963) The use of lead citrate at high pHas an electron-opaque stain in electron microscopy. J Cell Biol 17:208-212
60. Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni O (2002) Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci USA 99:8384-8388 (Pubitemid 34651061)
61. Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A (2008) Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology (Berl) 196:673-684
62. Seachrist J, Ferguson S (2003) Regulation of G protein-coupled receptor endocytosis and trafficking by Rab GTPases. Life Sci 74:225-235 (Pubitemid 37357054)
63. Sesack S, Grace A (2010) Cortico-Basal Ganglia reward network: microcircuitry. Neuropsychopharmacology 35:27-47
64. Skinbjerg M, Liow JS, Seneca N, Hong J, Lu S, Thorsell A, Heilig M, Pike VW, Halldin C, Sibley DR, Innis RB (2010) D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalizationdeficient mouse model. NeuroImage 50:1402-1407
65. Smith Y, Parent A, Seguela P, Descarries L (1987) Distribution of GABA-immunoreactive neurons in the basal ganglia of the squirrel monkey (Saimiri sciureus). J Comp Neurol 259:50-64 (Pubitemid 17051903)
66. Soiza-Reilly M, Azcurra J (2009) Developmental striatal critical period of activity-dependent plasticity is also a window of susceptibility for haloperidol induced adult motor alterations. Neurotoxicol Teratol 31:191-197
67. Swanson C, Heath S, Stratford T, Kelley A (1997) Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmacol Biochem Behav 58:933-945 (Pubitemid 28108200)
68. Tirotta E, Fontaine V, Picetti R, Lombardi M, Samad T, Oulad- Abdelghani M, Edwards R, Borrelli E (2008) Signaling by dopamine regulates D2 receptors trafficking at the membrane. Cell Cycle 7:2241-2248 (Pubitemid 352031527)
69. Torrealba F, Müller C (1999) Ultrastructure of glutamate and GABA immunoreactive axon terminals of the rat nucleus tractus solitarius, with a note on infralimbic cortex afferents. Brain Res 820:20-30 (Pubitemid 29225475)
70. van der Stelt M, Di MV (2003) The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur J Pharmacol 480:133-150
71. Van Hartesveldt C (1997) Temporal and environmental effects on quinpirole-induced biphasic locomotion in rats. Pharmacol Biochem Behav 58:955-960
72. Van Hartesveldt C, Cottrell GA, Potter T, Meyer ME (1992) Effects of intracerebral quinpirole on locomotion in rats. Eur J Pharmacol 214:27-32
73. Wager-Miller J, Westenbroek R, Mackie K (2002) Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. Chem Phys Lipids 121:83-89 (Pubitemid 36044545)
74. Wang Z, Kai L, Day M, Ronesi J, Yin H, Ding J, Tkatch T, Lovinger D, Surmeier D (2006) Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50:443-452
75. Xiao MF, Xu JC, Tereshchenko Y, Novak D, Schachner M, Kleene R (2009) Neural cell adhesion molecule modulates dopaminergic signaling and behavior by regulating dopamine D2 receptor internalization. J Neurosci 29:14752-14763
76. Yao W, Spealman R, Zhang J (2008) Dopaminergic signaling in dendritic spines. Biochem Pharmacol 75:2055-2069
77. Zahm D (2000) An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci Biobehav Rev 24:85-105